Magellan Health Insights
  • Home
  • About
  • Resources
  • Voices
  • Contact

Podcast of Interest – Mostafa Kamal Talks PBM

by Mostafa Kamal August 17, 2020COVID-19, Pharmacy

Did you hear? Mostafa Kamal, chief executive officer, Magellan Rx Management, sat down with PCMA to talk about Magellan Rx, the journey to becoming a next gen PBM, and what the future of the industry looks like. If you haven’t listened yet, search for “The Pharmacy Benefit” wherever you listen to your podcasts and stream “How Technology Improves Patient Outcomes (Especially in the COVID-19 Age).”

Here are a few episode highlights:

  1. Magellan Rx solves complex pharmacy challenges. Our associates are the key ingredient to our success. We are always rolling up our sleeves and leaning into the challenges facing our customers and members, innovating and discovering opportunities to bring value to those we serve.
  2. Market leaders in Medicaid Fee-for-Service. As the pharmacy program provider for 26 states and Washington, D.C., we provide real-time claims processing and prior authorization administration. This means when a Medicaid member visits the pharmacy for a prescription, the pharmacy can pull up all the information it needs to process these claims right then and there – so simple, and SO important. States have strict budgets, and it’s important that Medicaid programs stay in budget. We help drive down costs to Medicaid plans, AND 100% of the rebates go back into the state.
  3. Pharmacy Benefits Management (PBM) can be confusing! While not everyone understands the complexities of the PBM industry, we play a very important role as we are at the nexus of caring for people, delivering innovative solutions and generating savings for the healthcare system.
  4. Disruptors in healthcare inspire innovation. Right now, inefficiencies in the healthcare system are evident as a result of COVID-19. We want a vaccine, treatment, better testing, and we want it three months ago. But look at what it has fueled – we’re now working faster and smarter than ever before to solve a global need.
  5. Our industry isn’t that different from others. Every industry has been forced to grow and pivot at light speed as a result of COVID-19 and while it probably shouldn’t have taken a global pandemic to spur some of these changes, we are seeing organizations evolve at a rapid pace.
  6. Medication adherence is everything. We can’t emphasize this enough. If people take their medications as prescribed, they can avoid costly ER visits, complications, and a whole host of other challenges. The issue is, solving this problem is not as easy as reminding people to “just take your meds.” Patients with chronic conditions are often impacted by social determinants of health. If money is tight and you’re working multiple jobs to stay afloat, taking your medications as directed is probably not #1 on your list.
  7. Personalized treatment is the future. Think about the progress we’ve made with gene and cell therapies. Imagine a world with personalized formularies based on your genetic code and how your body metabolizes medications being the new normal. Everyone is different and targeted treatments are the path forward; after all, don’t you want your medication(s) to work for your specific genetic makeup? Now that’s a game-changer.

Who’s excited to see what the future holds?! (we need something to be excited about in the middle of a pandemic so let’s choose the future of pharmacy and the major role our industry plays in this new world).

Share on FacebookShare on TwitterShare on Linkedin
Tags: COVID-19, Healthcare Technology, Magellan Health, Magellan RX, Magellan Rx Management, medication adherence, MRx, PBM, Personalized Treatment, Pharmacy Benefit Management, Technology
Mostafa Kamal
Mostafa Kamal
As chief executive officer of Magellan Rx Management, Mostafa Kamal is responsible for all of Magellan's pharmacy business lines, including commercial, government and specialty pharmacy divisions. He leads the strategy, operations, profitability and growth of Magellan Rx Management with the overarching goal of delivering best-in-class drug management solutions that help clients improve the health of their members, and overall cost and quality of care. Before joining Magellan, he held various roles with Medco Health Solutions, Inc. with responsibility for pricing, underwriting, strategy and Medicare Part D products and services. Additionally, he worked with clients to develop strategies to address health care reform and associated product offerings to ensure clients were successfully positioned in the post-health care reform era. Kamal received his bachelor of science in economics from Rutgers University.
Previous post Autism Spectrum Disorder Diagnosis in the Time of Coronavirus: A Conversation with Magellan’s Yagnesh Vadgama Next post Telehealth: Care and Treatment Wherever You Are

Related Articles

2017-06-12 12_54_10-Mens Health Infographic - Windows Photo Viewer

June is Men’s Health Month

by MHI Admin
June 12, 2017
Magellan in the News

In the Battle Against Opioid Addiction, Most Patients Lack Access to Key Treatment

by Caroline Carney, MD
January 23, 2018
Children's Mental Health

FAQs about children’s mental health

by Magellan Health Insights
August 7, 2018

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Magellan Health Logo

To learn more about how Magellan can support your organization, please visit MagellanHealth.com.

Topic suggestions or questions?
Send us your ideas at

Connect with us:

Trending Topics

  • A Present Day Look at PTSD
  • Medicine Cabinet Minefield: How old prescriptions drugs are fueling an opioid addiction crisis
  • The Trends and Complexities of Provider-Administered Drugs

Categories

Stay in the Know

Get the latest news and trending insights sent straight to your inbox.


HomeAboutResourcesVoicesContact
© 1999-2016 Magellan Health, Inc. All Rights Reserved.